DRIVE PK: A Phase 2 Trial of AG-348 in Patients with Pyruvate Kinase Deficiency

被引：0
|
作者：
Barbier, Ann [1 ]
Silver, Bruce [2 ]
Merica, Elizabeth [1 ]
Cohen, Marvin [3 ]
Kung, Charles [1 ]
Yang, Hua [1 ]
Grace, Rachael F. [4 ]
Glader, Bertil [5 ]
Agresta, Sam [1 ]
机构：
[1] Agios Pharmaceut, Cambridge, MA USA
[2] Bruce A Silver Clin Sci & Dev, Dunkirk, MD USA
[3] MBC Pharma Solut, Newtown, PA USA
[4] Harvard Univ, Sch Med, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[5] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Genotype-Response Correlation in DRIVE PK, a Phase 2 Study of AG-348 in Patients with Pyruvate Kinase Deficiency
    Kung, Charles
    Kosinski, Penelope A.
    Mangus, Heidi
    Hua, Lei
    Connor, Gary
    Mobilia, Michelle
    Sullivan, Karen
    Frye, Sasha
    Jouvin, Marie-Helene
    Grace, Rachael F.
    Glader, Bertil
    Bowden, Chris
    BLOOD, 2018, 132
  • [2] Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency
    Grace, Rachael F.
    Layton, D. Mark
    Galacteros, Frederic
    Rose, Christian
    Barcellini, Wilma
    Morton, D. Holmes
    Van Beers, Eduard J.
    Yaish, Hassan M.
    Ravindranath, Yaddanapudi
    Kuo, Kevin H. M.
    Sheth, Sujit
    Kwiatkowski, Janet L.
    Silver, Bruce
    Kung, Charles
    Cohen, Marvin
    Yang, Hua
    Kosinski, Penelope A.
    Hua, Lei
    Barbier, Ann
    Glader, Bertil
    BLOOD, 2017, 130
  • [3] EFFECTS OF AG-348, A PYRUVATE KINASE ACTIVATOR, IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY: UPDATED RESULTS FROM THE DRIVE PK STUDY
    Grace, R. F.
    Layton, D. M.
    Galacteros, F.
    Rose, C.
    Barcellini, W.
    Morton, D. H.
    van Beers, E.
    Yaish, H.
    Ravindranath, Y.
    Kuo, K.
    Sheth, S.
    Kwiatkowski, J. L.
    Silver, B.
    Kung, C.
    Cohen, M.
    Yang, H.
    Kosinski, P. A.
    Hua, L.
    Barbier, A.
    Glader, B.
    HAEMATOLOGICA, 2017, 102 : 164 - 164
  • [4] Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study
    Grace, Rachael F.
    Rose, Christian
    Layton, D. Mark
    Yaish, Hassan M.
    Barcellini, Wilma
    Galacteros, Frederic
    Morton, D. Holmes
    Ravindranath, Yaddanapudi
    Kuo, Kevin H. M.
    van Beers, Eduard J.
    Kwiatkowski, Janet L.
    Silver, Bruce A.
    Merica, Elizabeth
    Kung, Charles
    Cohen, Marvin
    Yang, Hua
    Hixon, Jeffrey
    Kosinski, Penelope A.
    Silverman, Lee
    Dang, Lenny
    Yuan, Zheng
    Barbier, Ann J.
    Glader, Bertil
    BLOOD, 2016, 128 (22)
  • [5] EFFECTS OF AG-348, A PYRUVATE KINASE ACTIVATOR, ON ANEMIA AND HEMOLYSIS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY: EARLY DATA FROM THE DRIVE PK STUDY
    Grace, R. F.
    Rose, C.
    Layton, D. M.
    Barcellini, W.
    Kwiatkowski, J. L.
    Silver, B.
    Merica, E.
    Kung, C.
    Cohen, M.
    Yang, H.
    Hixon, J.
    Kosinski, P. A.
    Silverman, L.
    Dang, L.
    Yuan, Z. J.
    Barbier, A. J.
    Agresta, S.
    Glader, B.
    HAEMATOLOGICA, 2016, 101 : 169 - 169
  • [6] Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
    Grace, Rachael F.
    Layton, D. Mark
    Galacteros, Frederic
    Barcellini, Wilma
    van Beers, Eduard J.
    Yaish, Hassan M.
    Ravindranath, Yaddanapudi
    Kuo, Kevin H. M.
    Sheth, Sujit
    Kwiatkowski, Janet L.
    Hua, Lei
    Hawkins, Peter F.
    Mix, Chris
    Glader, Bertil
    BLOOD, 2019, 134
  • [7] AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency
    Kung, Charles
    Hixon, Jeff
    Kosinski, Penelope A.
    Cianchetta, Giovanni
    Histen, Gavin
    Chen, Yue
    Hill, Collin
    Gross, Stefan
    Si, Yaguang
    Johnson, Kendall
    DeLaBarre, Byron
    Luo, Zhiyong
    Gu, Zhiwei
    Yao, Gui
    Tang, Huachun
    Fang, Cheng
    Xu, Yingxia
    Lv, Xiaobing
    Biller, Scott
    Su, Shin-San Michael
    Yang, Hua
    Popovici-Muller, Janeta
    Salituro, Francesco
    Silverman, Lee
    Dang, Lenny
    BLOOD, 2017, 130 (11) : 1347 - 1356
  • [8] POPULATION PHARMACOKINETICS OF AG-348 IN HEALTHY VOLUNTEERS AND ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY.
    Jia, H.
    Iyer, V.
    Barbier, A. J.
    Hua, L.
    Mangus, H.
    Yang, H.
    Liang, M.
    Le, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S12 - S12
  • [9] Characterization of Metabolic Response to AG-348, an Allosteric Activator of Red Cell Pyruvate Kinase, in Healthy Volunteers and Pyruvate Kinase Deficiency Patients
    Chubukov, Victor
    Johnson, Kendall
    Kosinski, Penelope A.
    Clasquin, Michelle
    Jha, Abhishek
    Kim, Hyeryun
    Roddy, Thomas P.
    Merica, Elizabeth
    Barbier, Ann J.
    Dang, Lenny
    Silverman, Lee
    Kung, Charles
    BLOOD, 2016, 128 (22)
  • [10] AG-348 Activation of Pyruvate Kinase in Vivo Enhances Red Cell Glycolysis in Mice
    Kung, Charles
    Hill, Collin
    Chen, Yue
    Jha, Abhishek
    Kosinski, Penelope
    Clasquin, Michelle
    Si, Yaguang
    Kim, Hyeryun
    Hixon, Jeff
    Dang, Lenny
    Agresta, Sam
    Silverman, Lee
    Yang, Hua
    BLOOD, 2014, 124 (21)
12345